Clinical trial
Regression of Cervical Precancerous Lesions and Associated Risk Factors
NCT06147388 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regression of Cervical Precancerous Lesions and Associated Risk Factors
- Lead sponsor
- General University Hospital, Prague
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- July 1, 2027
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervix uteri sil, cin2, cin3, hpv